HomeIDXG • OTCMKTS
add
Interpace Biosciences Inc
Previous close
$1.68
Year range
$0.78 - $2.60
Market cap
7.41M USD
Avg Volume
9.56K
P/E ratio
2.67
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 12.04M | 9.21% |
Operating expense | 5.17M | -13.81% |
Net income | 2.06M | 1,078.29% |
Net profit margin | 17.12 | 976.73% |
Earnings per share | — | — |
EBITDA | 2.32M | 95.29% |
Effective tax rate | 0.19% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.02M | -60.25% |
Total assets | 12.97M | -18.63% |
Total liabilities | 25.46M | -19.45% |
Total equity | -12.49M | — |
Shares outstanding | 4.39M | — |
Price to book | -0.12 | — |
Return on assets | 44.93% | — |
Return on capital | -138.79% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 2.06M | 1,078.29% |
Cash from operations | 1.40M | 241.61% |
Cash from investing | -197.00K | 13.60% |
Cash from financing | -2.00M | -185.71% |
Net change in cash | -793.00K | -53.38% |
Free cash flow | 621.12K | 26.99% |
About
Founded
1986
Headquarters
Website
Employees
108
